Simon advises on a wide range of corporate and commercial transactions. He has extensive experience in public and private M&A and equity capital markets and acts for a number of listed companies, including Diageo, GlaxoSmithKline, John Wood Group, Morgan Advanced Materials, Ultra Electronics and Whitbread.

Simon is named as a leading individual in:

  • the Corporate/M&A: High-end Capability section of Chambers UK, 2018
  • the Corporate/M&A India section of Chambers Global, 2018

He is also a member of the Times Law Panel.

Highlights include advising:

  • GlaxoSmithKline on:
    • the creation of its consumer healthcare joint venture with Pfizer
    • the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever plc and the merger of Indian-listed GSK Consumer Healthcare Limited with Hindustan Unilever Limited
    • its buyout of Novartis' interest in their consumer healthcare joint venture
    • its three-part inter-conditional Vaccines, Oncology and Consumer Healthcare asset swap transaction with Novartis
    • various other transactions, including its agreement with Pfizer to create ViiV Healthcare, a specialist HIV company, its acquisition of the marketed product portfolio of UCB in various jurisdictions and the increase of its stake in its publicly-listed Consumer Healthcare subsidiary in India,
  • Whitbread on:
    • its sale of Costa to The Coca-Cola Company
    • various other transactions, including the disposal of its pubs and bars division, the disposal of its UK Marriott hotels, the sale of TGI Fridays and various hotel acquisitions for Premier Inn
  • Actelion on the $30 billion tender offer by Johnson & Johnson and the related demerger of a new R&D biotech company, Idorsia
  • Diageo on:
    • its United Spirits acquisition in 2012 by private acquisition, preferential allotment and tender offer as well as the subsequent 2014 tender offer to increase its stake
    • the sale of its interests in Jamaican-listed Desnoes & Geddes and Malaysian-listed Guinness Anchor Berhad to Heineken and its acquisition of additional shares in Ghana-listed Guinness Ghana Breweries
    • various other transactions, including its intended transaction to increase its stake in its Nigerian listed subsidiary, Guinness Nigeria
  • John Wood Group on:
    • its recommended all-share offer for Amec Foster Wheeler
    • its acquisition of PSN, the UK aspects of the disposal of its Well Support Division to GE, and its subsequent return of cash to shareholders
  • Reliance Communications on its transaction with Maxis Communications Berhad to combine its wireless business with Aircel
  • Catlin on its recommended cash and share acquisition by XL Group
  • ViiV Healthcare on its agreement with Shionogi to acquire exclusive global rights to the Shionogi-ViiV Healthcare joint venture assets and under which Shionogi became a shareholder in ViiV Healthcare alongside GlaxoSmithKline and Pfizer
  • Cazenove on the transaction with J.P. Morgan under which J.P. Morgan Cazenove became wholly-owned by J.P. Morgan
  • Corus on the competing bids by Tata Steel and CSN and the successful final offer by Tata Steel

List of all our partners